Partnerships Between Healthcare Insurers And Pharmaceutical Companies Promote Real-World Value
PwC's Health Research Institute (HRI) reports that market forces are driving new sector collaborations — pairing traditional drug makers with insurers, health systems, patient groups and technology firms — to maximize real-world value and health outcomes. Partnerships are leveraging personal health information as the newest currency in drug development and commercialization.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063